[Emergency Pod] Peptides - Part 1 with Sunita Mohanty of Ultralight

Christina Farr sits down with Sunita Mohanty, CEO and Co-founder of Ultralight, an AI-native operating system powering over 75 functional and longevity medicine clinics across the U.S. Sunita breaks down the regulatory whiplash driving a peptide black market, why the evidence base still hasn't caught up with patient demand, and why individual response varies so dramatically.

—
SPONSOR: Granola

Granola AI, The AI notepad for people in back-to-back meetings: https://granola.ai/liferswith code: LIFERS

Interested in sponsoring the show? lifers@a16zstudios.com

—
LINKS:
Ultralight: https://www.ultralighthealth.com/ 

Chrissy Farr on YouTube: https://www.youtube.com/@LiferswithChristinaFarr 
Chrissy Farr on Instagram: https://www.instagram.com/cfarr/ 
Subscribe to the Second Opinion Newsletter: https://secondopinion.media/ 
Chrissy’s Book: The Storyteller's Advantage: https://www.chrissyfarr.com/books 

 —
FOLLOW:
Sunita:
https://www.linkedin.com/in/sunita-mohanty/ 
https://x.com/sunitasmohanty 

Christina Farr:
https://www.linkedin.com/in/christinafarr/ 
https://x.com/chrissyfarr 

—
TIMESTAMPS:
(00:00) Intro
(00:22) Peptides everywhere
(01:00) Meet Sunita Mohanty
(01:58) Stacks and hype
(02:54) Gray areas and risks
(04:51) Finding trusted clinicians
(06:38) Sponsor: Granola
(07:17) Doctors as test subjects
(08:37) Why it skews male
(10:13) Prevention vs treatment
(11:37) Wrap